Topics

Lonza taps Cryoport to bolster cell and gene therapy delivery

09:29 EST 7 Nov 2019 | BioPharmaDive

The Swiss manufacturer inked a deal with the cold chain specialist, which works with sector leaders like Gilead, Novartis and Bluebird bio.

Original Article: Lonza taps Cryoport to bolster cell and gene therapy delivery

NEXT ARTICLE

More From BioPortfolio on "Lonza taps Cryoport to bolster cell and gene therapy delivery"

Quick Search

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...